Cencora Inc (NYSE:COR)
$ 251.55 1.86 (0.74%) Market Cap: 48.62 Bil Enterprise Value: 49.52 Bil PE Ratio: 33.50 PB Ratio: 76.00 GF Score: 85/100

Amerisourcebergen Corp at Barclays Global Healthcare Conference Transcript

Mar 15, 2022 / 06:00PM GMT
Release Date Price: $151.39 (+3.59%)
Steven James Valiquette
Barclays Bank PLC, Research Division - Research Analyst

All right. Great. We're going to get started with our next session here with AmerisourceBergen. I'm Steven Valiquette, the health care services analyst here at Barclays.

With us from the company, we have Steve Collis, company's CEO; and also Jim Cleary, the CFO. This will be a fireside chat. We'll dive into those questions in a few minutes here. But I think first, I'm going to turn it over to Steve just to give some comments.

Steven H. Collis
AmerisourceBergen Corporation - Chairman, President & CEO

Good afternoon, everyone. I appreciate your attendance here. I think this was right 2 years ago when we -- where we come in to Miami or not. And so that's right around when things started getting canceled. So I'm just going to make some introductory comments about AmerisourceBergen. We have had a few investors that have asked us for some more fundamental sort of discussions today. So we are a pharmaceutical services and distribution company focused on the prescription

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot